Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

245 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Overcoming resistance to HER2-targeted therapy with a novel HER2/CD3 bispecific antibody.
Lopez-Albaitero A, Xu H, Guo H, Wang L, Wu Z, Tran H, Chandarlapaty S, Scaltriti M, Janjigian Y, de Stanchina E, Cheung NK. Lopez-Albaitero A, et al. Among authors: de stanchina e. Oncoimmunology. 2017 Mar 10;6(3):e1267891. doi: 10.1080/2162402X.2016.1267891. eCollection 2017. Oncoimmunology. 2017. PMID: 28405494 Free PMC article.
Comprehensive molecular characterization of lung tumors implicates AKT and MYC signaling in adenocarcinoma to squamous cell transdifferentiation.
Quintanal-Villalonga A, Taniguchi H, Zhan YA, Hasan MM, Chavan SS, Meng F, Uddin F, Allaj V, Manoj P, Shah NS, Chan JM, Ciampricotti M, Chow A, Offin M, Ray-Kirton J, Egger JD, Bhanot UK, Linkov I, Asher M, Roehrl MH, Ventura K, Qiu J, de Stanchina E, Chang JC, Rekhtman N, Houck-Loomis B, Koche RP, Yu HA, Sen T, Rudin CM. Quintanal-Villalonga A, et al. Among authors: de stanchina e. J Hematol Oncol. 2021 Oct 16;14(1):170. doi: 10.1186/s13045-021-01186-z. J Hematol Oncol. 2021. PMID: 34656143 Free PMC article.
gC1qR/HABP1/p32 Is a Potential New Therapeutic Target Against Mesothelioma.
Peerschke E, Stier K, Li X, Kandov E, de Stanchina E, Chang Q, Xiong Y, Manova-Todorova K, Fan N, Barlas A, Ghebrehiwet B, Adusumilli PS. Peerschke E, et al. Among authors: de stanchina e. Front Oncol. 2020 Aug 12;10:1413. doi: 10.3389/fonc.2020.01413. eCollection 2020. Front Oncol. 2020. PMID: 32903438 Free PMC article.
Inhibitory monoclonal antibody targeting ADAM17 expressed on cancer cells.
Saha N, Xu K, Zhu Z, Robev D, Kalidindi T, Xu Y, Himanen J, de Stanchina E, Pillarsetty NVK, Dimitrov DS, Nikolov DB. Saha N, et al. Among authors: de stanchina e. Transl Oncol. 2022 Jan;15(1):101265. doi: 10.1016/j.tranon.2021.101265. Epub 2021 Nov 9. Transl Oncol. 2022. PMID: 34768098 Free PMC article.
Systematic Comparison of Pancreatic Ductal Adenocarcinoma Models Identifies a Conserved Highly Plastic Basal Cell State.
Pitter KL, Grbovic-Huezo O, Joost S, Singhal A, Blum M, Wu K, Holm M, Ferrena A, Bhutkar A, Hudson A, Lecomte N, de Stanchina E, Chaligne R, Iacobuzio-Donahue CA, Pe'er D, Tammela T. Pitter KL, et al. Among authors: de stanchina e. Cancer Res. 2022 Oct 4;82(19):3549-3560. doi: 10.1158/0008-5472.CAN-22-1742. Cancer Res. 2022. PMID: 35952360 Free PMC article.
Predicting Gemcitabine Delivery by 18F-FAC PET in Murine Models of Pancreatic Cancer.
Russell J, Grkovski M, O'Donoghue IJ, Kalidindi TM, Pillarsetty N, Burnazi EM, Kulick A, Bahr A, Chang Q, LeKaye HC, de Stanchina E, Yu KH, Humm JL. Russell J, et al. Among authors: de stanchina e. J Nucl Med. 2021 Feb;62(2):195-200. doi: 10.2967/jnumed.120.246926. Epub 2020 Jul 9. J Nucl Med. 2021. PMID: 32646874 Free PMC article.
Functional Genomics In Vivo Reveal Metabolic Dependencies of Pancreatic Cancer Cells.
Zhu XG, Chudnovskiy A, Baudrier L, Prizer B, Liu Y, Ostendorf BN, Yamaguchi N, Arab A, Tavora B, Timson R, Heissel S, de Stanchina E, Molina H, Victora GD, Goodarzi H, Birsoy K. Zhu XG, et al. Among authors: de stanchina e. Cell Metab. 2021 Jan 5;33(1):211-221.e6. doi: 10.1016/j.cmet.2020.10.017. Epub 2020 Nov 4. Cell Metab. 2021. PMID: 33152324 Free PMC article.
245 results